本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Crinetics Pharmaceuticals Inc.

31.11
-1.9100-5.78%
成交量:92.35万
成交额:2,940.59万
市值:29.14亿
市盈率:-8.15
高:33.22
开:33.07
低:30.84
收:33.02
数据加载中...
2024/03/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/19

重要事件披露

Form 8-K - Current report
2024/03/12

重要事件披露

Form 8-K - Current report
2024/03/11

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/03/01

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/03/01

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/03/01

重要事件披露

Form 8-K - Current report
2024/02/29

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/29

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/28

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]